CellSource Co.,Ltd.【JP:4880】Other
Market cap
¥7.6B
P/E ratio
-55.4x
CellSource processes blood and fat tissue into therapeutic substances for medical institutions offering regenerative medicine treatments like knee osteoarthritis and infertility care.
| 2016/10 | 2017/10 | 2018/10 | 2019/10 | 2020/10 | 2021/10 | 2022/10 | 2023/10 | 2024/10 | 2025/10 | |
| Return on Assets | - | - | - | 15.7 | 13.1 | 22.8 | 25.6 | 16.1 | 3.4 | 0.2 |
| Return on equity (%) | - | - | ||||||||
| Employees | 6 | 13 | 39 | 58 | 68 | 90 | 109 | 151 | 157 | 148 |
| Total payout ratio | - | - | - | - | - | - | - | - | 165.4 | - |